In previous in vitro studies, by inducing cellular transgenic activation of SGK1, we demonstrated as this kinase protected kidney cells from apoptosis (Pastore et al., 2015), and endothelial cells from oxidative stress and hyperglycemia (Ferrelli et al., 2015). The gene discussed is SGK1; the disease is Hyperglycemia.